Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Other Non-Current Liabilities of $630.7 million for Q1 2026, up 358.02% year-over-year from $137.7 million in Q1 2025, and up 0.73% quarter-over-quarter from $626.1 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $630.7 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 358.02% year-over-year to $630.7 million; the TTM figure through Mar 2026 stood at $630.7 million (up 358.02% YoY), while the FY2025 annual figure was $626.1 million, up 246.49% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $630.7 million, up from $626.1 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $1.2 billion in Q2 2024, with the low at $137.7 million in Q1 2025.
- The 5-year median for Other Non-Current Liabilities is $630.7 million (2026), against an average of $633.1 million.
- The sharpest annual moves came in 2024 and 2026: Other Non-Current Liabilities tumbled 80.48% in 2024, then surged 358.02% in 2026.
- Zimmer Biomet Holdings' Other Non-Current Liabilities stood at $632.6 million in 2022, then soared by 46.35% to $925.8 million in 2023, then sank by 80.48% to $180.7 million in 2024, then jumped by 246.49% to $626.1 million in 2025, then advanced by 0.73% to $630.7 million in 2026.
- Business Quant data shows ZBH's Other Non-Current Liabilities at $630.7 million in Q1 2026, $626.1 million in Q4 2025, and $806.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.29 Bn | 18.88 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 638.70 Mn |
| Mar 31, 2026 | 630.70 Mn |
| Dec 31, 2025 | 626.10 Mn |
| Sep 30, 2025 | 806.40 Mn |
| Jun 30, 2025 | 878.80 Mn |
| Mar 31, 2025 | 137.70 Mn |
| Dec 31, 2024 | 180.70 Mn |
| Sep 30, 2024 | 1.03 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 275.80 Mn |
| Dec 31, 2023 | 925.80 Mn |
| Sep 30, 2023 | 403.10 Mn |
| Jun 30, 2023 | 642.00 Mn |
| Mar 31, 2023 | 637.40 Mn |
| Dec 31, 2022 | 632.60 Mn |
| Sep 30, 2022 | 608.70 Mn |
| Jun 30, 2022 | 591.00 Mn |
| Mar 31, 2022 | 552.50 Mn |
| Dec 31, 2021 | 548.50 Mn |
| Sep 30, 2021 | 596.60 Mn |